E-LIB Suche - Ergebnisse für: Santagostino, Elena

1

Real-world usage and effectiveness of recombinant factor VI..:

Bidlingmaier, Christoph ; Heller, Christine ; Langer, Florian...
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 5 - p. 102482 , 2024

Link: https://doi.org/10.1016/..

2

A post hoc analysis of previously untreated patients with s..:

Carcao, Manuel ; Schiavulli, Michele ; Kulkarni, Roshni...
Blood Advances. 8 (2024) 6 - p. 1494-1503 , 2024

Link: https://doi.org/10.1182/..

3

Recombinant factor IX Fc for major surgery in hemophilia B:..:

Shapiro, Amy D. ; Chambost, Hervé ; Ozelo, Margareth C....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) 6 - p. 102169 , 2023

Link: https://doi.org/10.1016/..

4

A global comparative field study to evaluate the factor VII..:

Pipe, Steven ; Sadeghi‐Khomami, Ali ; Konkle, Barbara A....
Haemophilia. 30 (2023) 1 - p. 214-223 , 2023

Link: https://doi.org/10.1111/..

5

Pharmacokinetic parameters of recombinant factor IX Fc fusi..:

Sidonio Jr, Robert F. ; Casiano, Sandra ; Falk, Aletta...
Haemophilia. 29 (2022) 1 - p. 404-407 , 2022

Link: https://doi.org/10.1111/..

6

Phase 2 study of avatrombopag in Japanese patients with chr..:

Eguchi, Yuichiro ; Takahashi, Hirokazu ; Mappa, Silvia.
Hepatology Research. 52 (2022) 4 - p. 371-380 , 2022

Link: https://doi.org/10.1111/..

7

rFIXFc prophylaxis improves pain and levels of physical act..:

Astermark, Jan ; Hermans, Cédric ; Ezzalfani, Monia...
Haemophilia. 28 (2021) 1 - p. 18-26 , 2021

Link: https://doi.org/10.1111/..

8

Efficacy of rFVIIIFc versus Emicizumab for the Treatment of..:

Klamroth, Robert ; Wojciechowski, Piotr ; Aballéa, Samuel...
Journal of Blood Medicine. 12 (2021) - p. 115-122 , 2021

Link: https://doi.org/10.2147/..

9

Comparison of quality of life, and emotional and functional..:

Riva, Silvia ; Marchesini, Emanuela ; Oliovecchio, Emily...
Haemophilia. 27 (2021) 4 - p. , 2021

Link: https://doi.org/10.1111/..

10

Predictors of inhibitor eradication by primary immune toler..:

Di Minno, Giovanni ; Coppola, Antonio ; Margaglione, Maurizio...
Haemophilia. 28 (2021) 1 - p. 55-64 , 2021

Link: https://doi.org/10.1111/..

11

Safety and efficacy of BAY 94–9027, an extended‐half‐life f..:

Santagostino, Elena ; Lalezari, Shadan ; Reding, Mark T....
Haemophilia. 27 (2021) 4 - p. , 2021

Link: https://doi.org/10.1111/..

12

Principles of care for acquired hemophilia:

Dolan, Gerry ; Benson, Gary ; Bowyer, Annette...
European Journal of Haematology. 106 (2021) 6 - p. 762-773 , 2021

Link: https://doi.org/10.1111/..

13

Practical considerations for nonfactor‐replacement therapie..:

Jiménez‐Yuste, Victor ; Auerswald, Günter ; Benson, Gary...
Haemophilia. 27 (2021) 3 - p. 340-350 , 2021

Link: https://doi.org/10.1111/..

14

Inhibitor incidence in an unselected cohort of previously u..:

Male, Christoph ; Andersson, Nadine G. ; Rafowicz, Anne...
Haematologica. 106 (2020) 1 - p. 123-129 , 2020

Link: https://doi.org/10.3324/..

15

High adherence to prophylaxis regimens in haemophilia B pat..:

Mancuso, Maria Elisa ; Oldenburg, Johannes ; Boggio, Lisa...
Haemophilia. 26 (2020) 4 - p. 637-642 , 2020

Link: https://doi.org/10.1111/..